Faron would have already monetized Traumakine IF it had significant value for the company’s financing needs.
In my understanding and memory, Faron bought the rights to Traumakine for peanuts back in the day. Hype was built around Traumakine during the COVID-19 era until it was found to be ineffective for that purpose as well. Before this, the drug’s effectiveness on the battlefield had been found to be poor.
I find it impossible to understand why Traumakine should be highlighted in any special way in this situation. It doesn’t really change much if someone pays a few million for the rights to Traumakine, just as Faron did back then.
Edit: Here is the most important observation regarding Traumakine: